drugset
Drugs / BioNTech - Pfizer COVID-19 vaccine
last change May 2025 re-read 2 minutes ago

BioNTech - Pfizer COVID-19 vaccine

also known as Cominarty

Messenger RNA (mRNA)

Developed for
COVID-19
Investigated by
Merck Sharp & Dohme LLC · Project San Francisco · Rwanda Biomedical Centre · University of Birmingham

Trials 1 · a red edge is where a trial was stopped

today NCT06587503 · Ph 4
20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06587503 Oct → Dec 2024 overdue COVID-19, Ebola hemorrhagic fever University of Birmingham Not yet recruiting No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05142514 Comparator Nov → Dec 2021 COVID-19 Hipra Scientific, S.L.U Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as BioNTech - Pfizer COVID-19 vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT06587503 ↗
Known as Cominarty ClinicalTrials.gov intervention name — accepted as the source's own label NCT05142514 ↗
Modality Vaccine “Commercial COVID-19 Vaccine” NCT05142514 ↗
Route Intramuscular “Receive an intramuscular dose of BioNTech - Pfizer COVID-19 concurrently with a dose of rVSV∆G-ZEBOV-GP vaccine” NCT06587503 ↗